PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to tame debilitating skin itch in major trial
Disease control Recruiting nowThis study is testing whether an oral medication called povorcitinib can reduce severe, persistent itch and heal skin lesions in people with prurigo nodularis, a chronic skin condition. About 330 adults with moderate-to-severe disease will take either the drug or a placebo pill f…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
First test of new hope for unbearable itch
Disease control Recruiting nowThis is the first time a new drug called BGB-45035 is being tested in people. The main goal is to check if it is safe and how the body processes it. The study will first give the drug to healthy volunteers at different doses. Later, a small group of adults with itchy skin conditi…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for kids with severe itchy skin disease
Disease control Recruiting nowThis study aims to understand how the drug dupilumab behaves in the body and how safe it is for children and teenagers with a severe, itchy skin condition called prurigo nodularis. About 18 participants, aged 6 months to under 18 years, will receive the drug for 24 weeks and be f…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New pill aims to tame debilitating skin itch in Final-Stage trial
Disease control Recruiting nowThis study is testing whether an oral medication called povorcitinib can reduce severe itching and heal skin lesions in people with prurigo nodularis, a chronic skin condition. About 330 adults with moderate-to-severe symptoms who haven't responded well to other treatments will r…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC